Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Hologic (HOLX) PT Lowered to $48 at Piper Jaffray Following 4Q Release
November 9, 2017 8:19 AM ESTPiper Jaffray lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $51.00) while maintaining a Overweight rating following the company's 4Q earnings report. Hologic reported a 10.5% 4Q17 revenue increase to $802.9M, above $793M consensus. Adjusted EPS of $0.50 beat the Street's $0.49 forecast. Hologic issued 2018 revenue... More



